Poland· PL-100384233

Furaginum Teva

A furazidin product containing furazidinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o..

ATC J01XE03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFuraginum TevaATCJ01XE03REGISTER NO.PL-100384233PACKS LISTED3CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Furazidinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
J01XE03
ATC class
Furazidin
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

1 priced
  • gtin
    05909991373214
  • gtin
    05909991373221
  • gtin
    05909991373238
    30 szt.
    PLN 10.94

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9076d9e7-437b-441f-b96f-18a01d84efd7
GET /v1/drugs/9076d9e7-437b-441f-b96f-18a01d84efd7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05909991373214 ¦ Rp ¦ 128261\n15 tabl.\n05909991373221 ¦ Rp ¦ 128262\n25 tabl.\n05909991373238 ¦ Rp ¦ 128263\n30 tabl.",
  "substance": "Furazidinum 100 mg",
  "common_name": "Furazidinum",
  "pl_product_id": "100384233",
  "pozwolenie_nr": "24734",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about furazidin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.